Article info

Download PDFPDF
Original research
Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Authors

  1. Correspondence to Dr George Zogopoulos, McGill University Health Centre, 1001 boul. Decarie, Rm EM2.3210, Montreal, Québec, Canada; george.zogopoulos{at}mcgill.ca
View Full Text

Citation

Wang Y, Golesworthy B, Cuggia A, et al
Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Publication history

  • Received June 24, 2021
  • Accepted September 7, 2021
  • First published September 23, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.